Beta Bionics (BBNX) Competitors $11.05 +0.06 (+0.55%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX vs. WRBY, CNMD, PLSE, KMTS, CDRE, LQDA, BLFS, TNDM, INMD, and FNAShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include Warby Parker (WRBY), CONMED (CNMD), Pulse Biosciences (PLSE), Kestra Medical Technologies (KMTS), Cadre (CDRE), Liquidia (LQDA), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), InMode (INMD), and Paragon 28 (FNA). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Warby Parker CONMED Pulse Biosciences Kestra Medical Technologies Cadre Liquidia BioLife Solutions Tandem Diabetes Care InMode Paragon 28 Warby Parker (NYSE:WRBY) and Beta Bionics (NASDAQ:BBNX) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability. Do institutionals and insiders believe in WRBY or BBNX? 93.2% of Warby Parker shares are owned by institutional investors. 26.5% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer WRBY or BBNX? Warby Parker received 43 more outperform votes than Beta Bionics when rated by MarketBeat users. However, 66.67% of users gave Beta Bionics an outperform vote while only 45.37% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformWarby ParkerOutperform Votes4945.37% Underperform Votes5954.63% Beta BionicsOutperform Votes666.67% Underperform Votes333.33% Which has preferable earnings and valuation, WRBY or BBNX? Beta Bionics has lower revenue, but higher earnings than Warby Parker. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$771.32M2.22-$63.20M-$0.17-97.12Beta Bionics$65.12M7.36N/AN/AN/A Is WRBY or BBNX more profitable? Beta Bionics has a net margin of 0.00% compared to Warby Parker's net margin of -4.39%. Beta Bionics' return on equity of 0.00% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-4.39% -8.26% -4.37% Beta Bionics N/A N/A N/A Does the media prefer WRBY or BBNX? In the previous week, Warby Parker had 14 more articles in the media than Beta Bionics. MarketBeat recorded 18 mentions for Warby Parker and 4 mentions for Beta Bionics. Warby Parker's average media sentiment score of 1.07 beat Beta Bionics' score of 0.94 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 11 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Beta Bionics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend WRBY or BBNX? Warby Parker currently has a consensus target price of $22.50, indicating a potential upside of 36.28%. Beta Bionics has a consensus target price of $24.83, indicating a potential upside of 124.74%. Given Beta Bionics' stronger consensus rating and higher probable upside, analysts clearly believe Beta Bionics is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 6 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.69Beta Bionics 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 SummaryWarby Parker and Beta Bionics tied by winning 7 of the 14 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$479.01M$4.39B$5.56B$7.82BDividend YieldN/A39.94%5.11%4.22%P/E RatioN/A30.6722.5118.48Price / Sales7.3654.91395.68103.60Price / CashN/A51.0838.1834.62Price / BookN/A6.116.774.25Net IncomeN/A$68.15M$3.22B$248.23M7 Day Performance-0.09%-0.12%1.45%0.89%1 Month Performance-1.69%-2.24%3.97%3.53%1 Year PerformanceN/A24.15%16.14%5.08% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta BionicsN/A$11.05+0.5%$24.83+124.7%N/A$479.01M$65.12M0.00294WRBYWarby Parker3.8606 of 5 stars$15.81+6.0%$22.93+45.0%+40.7%$1.64B$771.32M-58.563,030Upcoming EarningsAnalyst UpgradePositive NewsCNMDCONMED4.6023 of 5 stars$50.99+2.6%$77.20+51.4%-28.1%$1.58B$1.31B12.034,100Earnings ReportAnalyst DowngradeNews CoveragePLSEPulse Biosciences1.161 of 5 stars$19.27+6.0%N/A+130.9%$1.30B$700,000.000.00140Upcoming EarningsGap DownKMTSKestra Medical TechnologiesN/A$24.99+2.7%$27.50+10.0%N/A$1.24B$45.82M0.00300CDRECadre3.7334 of 5 stars$30.01+2.1%$37.00+23.3%-12.6%$1.22B$567.56M36.162,240Upcoming EarningsPositive NewsLQDALiquidia2.8519 of 5 stars$14.03+3.5%$26.63+89.8%+8.7%$1.20B$14.00M-8.6150Positive NewsBLFSBioLife Solutions2.506 of 5 stars$24.80+1.8%$31.17+25.7%+37.5%$1.18B$82.25M-23.40440Upcoming EarningsPositive NewsTNDMTandem Diabetes Care4.6389 of 5 stars$17.67+6.6%$43.88+148.3%-54.1%$1.18B$940.20M-9.162,600News CoveragePositive NewsINMDInMode3.3985 of 5 stars$16.13+3.5%$21.25+31.7%-18.0%$1.12B$394.82M6.86480Earnings ReportAnalyst ForecastOptions VolumeNews CoverageGap DownFNAParagon 281.5458 of 5 stars$13.11+0.1%$14.20+8.4%+42.1%$1.10B$256.18M-17.71343,000High Trading Volume Related Companies and Tools Related Companies Warby Parker Competitors CONMED Competitors Pulse Biosciences Competitors Kestra Medical Technologies Competitors Cadre Competitors Liquidia Competitors BioLife Solutions Competitors Tandem Diabetes Care Competitors InMode Competitors Paragon 28 Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBNX Stock Free BBNX Stock Alerts